Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

Since intensive glucose control with metformin appears to reduce the risk of diabetes relat- ed end points, especially myocardial infarction and fatal coronary deaths, in

Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system.. M

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.. Diabetes Res

4.7 Application to composite volume elements This section presents a few examples of representative volume elements un- der different loading conditions and provides a better insight

Nem as interpolações de raiz ptolomaica, nem a decomposição sub-regional de cada uma das nove unidades asiáticas pré-definidas perturbam o essencial da leitura proposta por

Dual add-on therapy in type 2 diabetes poorly controlled with metfor- min monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus

SHORT-TERM TREATMENT WITH METFORMIN IMPROVES THE CARDIOVASCULAR RISK PROFILE IN FIRST-DEGREE RELATIVES OF SUBJECTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE A METABOLIC SYNDROME

METHODS: A prospective study was performed in 16 uncontrolled patients with diabetes previously treated with dietary intervention. The participants were randomized into metformin